Organic–Inorganic Composites for Bone Drug Delivery

This review paper attempts to provide an overview in the fabrication and application of organic–inorganic based composites in the field of local drug delivery for bone. The concept of local drug delivery exists for a few decades. However, local drug delivery in bone and specially application of composites for delivery of drugs to bone is an area for potential research interest in the recent time. The advantages attained by an organic–inorganic composite when compared to its individual components include their ability to release drug, adopting to the natural environment and supporting local area until complete bone regeneration, which make them carriers of interest for local drug delivery for bone.

[1]  P Geusens,et al.  Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. , 2001, The New England journal of medicine.

[2]  Hyoun‐Ee Kim,et al.  Degradation and drug release of phosphate glass/polycaprolactone biological composites for hard-tissue regeneration. , 2005, Journal of biomedical materials research. Part B, Applied biomaterials.

[3]  Miqin Zhang,et al.  Cell growth and function on calcium phosphate reinforced chitosan scaffolds , 2004, Journal of materials science. Materials in medicine.

[4]  G. Goissis,et al.  The controlled release of antibiotic by hydroxyapatite: anionic collagen composites. , 1998, Artificial organs.

[5]  Hyoun‐Ee Kim,et al.  Hydroxyapatite porous scaffold engineered with biological polymer hybrid coating for antibiotic Vancomycin release , 2005, Journal of materials science. Materials in medicine.

[6]  Qixin Zheng,et al.  Porous nano-HA/collagen/PLLA scaffold containing chitosan microspheres for controlled delivery of synthetic peptide derived from BMP-2. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[7]  W. Ortega-Lara,et al.  Mechanical properties and apatite-forming ability of PMMA bone cements , 2009 .

[8]  M. Vallet‐Regí,et al.  In vitro bioactivity and gentamicin release from glass-polymer-antibiotic composites. , 2000, Journal of biomedical materials research.

[9]  R. Chung,et al.  Antimicrobial prophylaxis in surgery. , 2001, The Medical letter on drugs and therapeutics.

[10]  J. Knowles.  Phosphate based glasses for biomedical applications , 2003 .

[11]  F. Korkusuz,et al.  Development of a calcium phosphate-gelatin composite as a bone substitute and its use in drug release. , 1999, Biomaterials.

[12]  S. Pestotnik,et al.  The epidemiology of nephrotoxicity associated with conventional amphotericin B therapy. , 2001, The American journal of medicine.

[13]  J. Knuuti,et al.  Efficacy of Ciprofloxacin-Releasing Bioabsorbable Osteoconductive Bone Defect Filler for Treatment of Experimental Osteomyelitis Due to Staphylococcus aureus , 2005, Antimicrobial Agents and Chemotherapy.

[14]  Haitao Wang,et al.  Structure and release behavior of PMMA/silica composite drug delivery system. , 2007, Journal of pharmaceutical sciences.

[15]  Maryam Tabrizian,et al.  Responses of mesenchymal stem cell to chitosan-coralline composites microstructured using coralline as gas forming agent. , 2006, Biomaterials.

[16]  Miqin Zhang,et al.  Calcium phosphate/chitosan composite scaffolds for controlled in vitro antibiotic drug release. , 2002, Journal of biomedical materials research.

[17]  T. Niemelä.  Effect of β-tricalcium phosphate addition on the in vitro degradation of self-reinforced poly-l,d-lactide , 2005 .

[18]  Y. Matsusue,et al.  Histomorphometric study on high-strength hydroxyapatite/poly(L-lactide) composite rods for internal fixation of bone fractures. , 2000, Journal of biomedical materials research.

[19]  M. Vallet‐Regí,et al.  Bioactivity in glass/PMMA composites used as drug delivery system. , 2001, Biomaterials.

[20]  A Delgado,et al.  Ciprofloxacin implants for bone infection. In vitro-in vivo characterization. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[21]  H. Hsieh,et al.  Fabrication and release behavior of a novel freeze-gelled chitosan/gamma-PGA scaffold as a carrier for rhBMP-2. , 2006, Dental materials : official publication of the Academy of Dental Materials.

[22]  A R Boccaccini,et al.  Porous poly(alpha-hydroxyacid)/Bioglass composite scaffolds for bone tissue engineering. I: Preparation and in vitro characterisation. , 2004, Biomaterials.

[23]  T. Ikoma,et al.  Intraosseous delivery of paclitaxel-loaded hydroxyapatitealginate composite beads delaying paralysis caused by metastatic spine cancer in rats. , 2008, Journal of neurosurgery. Spine.

[24]  Yingjun Wang,et al.  Fabrication, characterization and long-term in vitro release of hydrophilic drug using PHBV/HA composite microspheres , 2007 .

[25]  I. Uygur,et al.  Elution characteristics and mechanical properties of calcium sulfate-loaded bone cement containing teicoplanin , 2007, Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association.

[26]  M. Otsuka,et al.  Bone Regeneration by Using Drug Delivery System Technology and Apatite Intelligent Materials , 2005 .

[27]  C. Ranawat,et al.  A prospective study of the progression of rheumatoid arthritis of the cervical spine. , 1981, The Journal of bone and joint surgery. American volume.

[28]  N. Passuti,et al.  Antibiotic-loaded bone cement in orthopedic surgery. , 2003, Joint, bone, spine : revue du rhumatisme.

[29]  H W Buchholz,et al.  Management of deep infection of total hip replacement. , 1981, The Journal of bone and joint surgery. British volume.

[30]  J. Xue,et al.  PLGA/mesoporous silica hybrid structure for controlled drug release. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[31]  A. Boccaccini,et al.  Biodegradable and bioactive porous polymer/inorganic composite scaffolds for bone tissue engineering. , 2006, Biomaterials.

[32]  B. Hanson,et al.  Global burden of trauma: Need for effective fracture therapies , 2009, Indian journal of orthopaedics.

[33]  Gwo‐Jaw Wang,et al.  Controlled release carrier of BSA made by W/O/W emulsion method containing PLGA and hydroxyapatite. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[34]  S. Teoh,et al.  An in vitro evaluation of PCL-TCP composites as delivery systems for platelet-rich plasma. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[35]  J. Knowles,et al.  Development of soluble glasses for biomedical use Part I: In vitro solubility measurement , 2000, Journal of materials science. Materials in medicine.

[36]  M. Sivakumar,et al.  Preparation, characterization and in vitro release of gentamicin from coralline hydroxyapatite-gelatin composite microspheres. , 2002, Biomaterials.

[37]  Liang Xu,et al.  Hydrophilic poly (ethylene glycol) coating on PDLLA/BCP bone scaffold for drug delivery and cell culture , 2008 .

[38]  Feza Korkusuz,et al.  Mechanical and Thermal Properties of Hydroxyapatite-Impregnated Bone Cement , 2000 .

[39]  J. Planell,et al.  Calcium phosphate cements: competitive drug carriers for the musculoskeletal system? , 2006, Biomaterials.

[40]  Jiang Chang,et al.  Preparation, characterization and in vitro release of gentamicin from PHBV/wollastonite composite microspheres. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[41]  M. Benson,et al.  Infection following total hip replacement in a general hospital without special orthopaedic facilities. , 1975, Acta orthopaedica Scandinavica.

[42]  C. Zalavras,et al.  Local antibiotic therapy in the treatment of open fractures and osteomyelitis. , 2004, Clinical orthopaedics and related research.

[43]  S. Girois,et al.  Polym. Degrad. Stab. , 1996 .

[44]  Henry C. Vasconez,et al.  Enhancement of Bone Growth by Sustained Delivery of Recombinant Human Bone Morphogenetic Protein-2 in a Polymeric Matrix , 2001, Pharmaceutical Research.

[45]  C. Chung,et al.  Transforming Growth Factor (TGF)-β1 Releasing Tricalcium Phosphate/Chitosan Microgranules as Bone Substitutes , 2004, Pharmaceutical Research.

[46]  O. Kilian,et al.  Glycerol-l-lactide coating polymer leads to delay in bone ingrowth in hydroxyapatite implants. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[47]  Juin-Yih Lai,et al.  Preparation of porous scaffolds by using freeze-extraction and freeze-gelation methods. , 2004, Biomaterials.

[48]  M. Vallet‐Regí,et al.  Drug Release and In Vitro Assays of Bioactive Polymer/Glass Mixtures , 2003 .

[49]  J. Czernuszka,et al.  Controlled release of amoxicillin from hydroxyapatite-coated poly(lactic-co-glycolic acid) microspheres. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[50]  T. Kissel,et al.  Controlled release of gentamicin from calcium phosphate-poly(lactic acid-co-glycolic acid) composite bone cement. , 2006, Biomaterials.

[51]  K. P. Rao,et al.  Preparation, characterization, and in vitro release of gentamicin from coralline hydroxyapatite-alginate composite microspheres. , 2003, Journal of biomedical materials research. Part A.

[52]  M. Vallet‐Regí,et al.  In vitro release of gentamicin from OHAp/PEMA/PMMA samples. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[53]  Jonathan C Knowles,et al.  Hydroxyapatite/poly(epsilon-caprolactone) composite coatings on hydroxyapatite porous bone scaffold for drug delivery. , 2004, Biomaterials.

[54]  J. Park,et al.  Processing of porous ceramic spheres by pseudo-double-emulsion method , 2003 .

[55]  P. D. Wilson,et al.  Infection rates after 3175 total hip and total knee replacements performed with and without a horizontal unidirectional filtered air-flow system. , 1982, The Journal of bone and joint surgery. American volume.

[56]  Dietmar W Hutmacher,et al.  Assessment of bone ingrowth into porous biomaterials using MICRO-CT. , 2007, Biomaterials.

[57]  J. San Román,et al.  Preparation, characterization, and in vitro release of ibuprofen from AI2O3/PLA/PMMA composites. , 1998, Journal of biomedical materials research.

[58]  P. Törmälä,et al.  In vitro and in vivo release of ciprofloxacin from osteoconductive bone defect filler. , 2005, The Journal of antimicrobial chemotherapy.

[59]  L. Ambrosio,et al.  Release kinetics of ampicillin, characterization and bioactivity of TiO2/PCL hybrid materials synthesized by sol-gel processing. , 2006, Journal of biomedical materials research. Part A.

[60]  D W Hutmacher,et al.  Novel PCL-based honeycomb scaffolds as drug delivery systems for rhBMP-2. , 2005, Biomaterials.

[61]  M. Catauro,et al.  Sol–gel processing of drug delivery zirconia/polycaprolactone hybrid materials , 2008, Journal of materials science. Materials in medicine.

[62]  E. Landi,et al.  Porous phosphate-gelatine composite as bone graft with drug delivery function , 2003, Journal of materials science. Materials in medicine.

[63]  O. Böstman,et al.  Clinical biocompatibility of biodegradable orthopaedic implants for internal fixation: a review. , 2000, Biomaterials.

[64]  A G Mikos,et al.  Controlled release of rhBMP-2 loaded poly(dl-lactic-co-glycolic acid)/calcium phosphate cement composites in vivo. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[65]  R. Legeros.  Calcium Phosphate-Based Osteoinductive Materials , 2009 .

[66]  M. Vallet‐Regí,et al.  Recent advances in ceramic implants as drug delivery systems for biomedical applications , 2008, International journal of nanomedicine.

[67]  G. Schmidmaier,et al.  Carrier systems and application of growth factors in orthopaedics. , 2008, Injury.

[68]  L. Rue,et al.  Site-specific delivery of acidic fibroblast growth factor stimulates angiogenic and osteogenic responses in vivo. , 2004, Journal of biomedical materials research. Part A.

[69]  G. Goissis,et al.  Nonstoichiometric hydroxyapatite-anionic collagen composite as support for the double sustained release of gentamicin and norfloxacin/ciprofloxacin. , 2000, Artificial organs.

[70]  M. Gardner,et al.  Osteoporosis and Skeletal Fractures , 2006, HSS Journal.

[71]  A. Yamazaki,et al.  Antibiotic-loaded poly-ε-caprolactone and porous β-tricalcium phosphate composite for treating osteomyelitis , 2008 .

[72]  P Stoodley,et al.  Survival strategies of infectious biofilms. , 2005, Trends in microbiology.

[73]  B. Eppley,et al.  Degradation Characteristics of PLLA‐PGA Bone Fixation Devices , 1997, The Journal of craniofacial surgery.

[74]  S. Best,et al.  Setting characteristics and mechanical behaviour of a calcium phosphate bone cement containing tetracycline. , 2001, Biomaterials.

[75]  F. Dorey,et al.  Deep sepsis following total knee arthroplasty. Ten-year experience at the University of California at Los Angeles Medical Center. , 1986, The Journal of bone and joint surgery. American volume.

[76]  Yang-Jo Seol,et al.  Enhanced bone formation by controlled growth factor delivery from chitosan-based biomaterials. , 2002, Journal of controlled release : official journal of the Controlled Release Society.